Medicines Discovery Catapult and SMi secure funding to validate cancer biomarker technology.
Read More
Following the award of a £1.9m grant from Innovate UK in 2021, SMi has again been successful in competing for a highly prestigious award for innovative research.
Read More
SMi has completed its first formal usability tests at the UK’s Medical Devices Testing and Evaluation Centre, located at the University Hospitals Birmingham NHS Foundation Trust.
Read More
SMi has achieved a great deal since starting its operations at the end of 2021. In addition to employing its full complement of scientists, engineers and regulatory specialists, SMi has also opened both its UK offices and US-based laboratories.
Read More